Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome: An economic evaluation

M. J. Nahuis, E. Oude Lohuis, N. Kose, N. Bayram, P. Hompes, G. J E Oosterhuis, E. M. Kaaijk, B. J. Cohlen, P. P M Bossuyt, F. Van Der Veen, B. W. Mol, M. Van Wely

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BACKGROUNDLaparoscopic electrocautery of the ovaries and ovulation induction with gonadotrophins are both second line treatments for women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS). Long-term follow-up after electrocautery versus ovulation induction with gonadotrophins has demonstrated at least comparable chances for a first live born child with a reduced need for ovulation induction or assisted reproduction treatment and increased chances for a second live born child. In this study, we report on the long-term economic consequences of both treatment modalities. METHODSBetween February 1998 and October 2001, we performed a multi-centre randomized controlled trial (RCT) comparing a strategy of laparoscopic electrocautery of the ovaries, followed by clomiphene citrate and gonadotrophins when anovulation persisted, and a strategy of ovulation induction with gonadotrophins in women with clomiphene citrate-resistant PCOS. Eight to twelve years after randomization we performed a follow-up study on reproductive outcome in these women and the fertility treatments they had needed including data on direct medical costs of pregnancy and delivery. Clinical data included number of treatment cycles, live births, miscarriages, ectopic pregnancies and multiple pregnancies. We calculated mean costs per woman after randomization until the first live birth. Confidence intervals (CIs) were estimated by bootstrapping. RESULTSWe obtained data for an economic analysis on 159 of the 168 randomized women (95). In total, 71 of 83 women (86) allocated to the electrocautery strategy and 69 of 85 women (81) allocated to the gonadotrophin strategy had at least one live birth. Given the equivalence between the two treatment strategies in terms of a first live birth-the primary outcome measure-our analysis focused on the cost difference between the two strategies within a mean follow-up time of 8-12 years. The mean costs per first live birth after randomization were €11 176 (95 CI: €9689-€12 549) for the electrocautery group and €14 423 (95 CI: €12 239-€16 606) for the recombinant FSH group, resulting in significantly lower costs (P < 0. 05) per first live birth for women allocated to the electrocautery group (mean difference €3247; 95 CI: €650-€5814). CONCLUSIONIn women with clomiphene-resistant PCOS, laparoscopic electrocautery of the ovaries results in significantly lower costs per live birth than ovulation induction with gonadotrophins for an at least equal effectiveness.

LanguageEnglish
Pages3577-3582
Number of pages6
JournalHuman Reproduction
Volume27
Issue number12
DOIs
Publication statusPublished - 1 Jan 2012

Keywords

  • cost-effectiveness
  • electrocautery
  • gonadotrophins
  • ovulation induction
  • polycystic ovary syndrome

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

Nahuis, M. J. ; Oude Lohuis, E. ; Kose, N. ; Bayram, N. ; Hompes, P. ; Oosterhuis, G. J E ; Kaaijk, E. M. ; Cohlen, B. J. ; Bossuyt, P. P M ; Van Der Veen, F. ; Mol, B. W. ; Van Wely, M. / Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome : An economic evaluation. In: Human Reproduction. 2012 ; Vol. 27, No. 12. pp. 3577-3582.
@article{a5ac410dfc424f7fb042c75d296a41d6,
title = "Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome: An economic evaluation",
abstract = "BACKGROUNDLaparoscopic electrocautery of the ovaries and ovulation induction with gonadotrophins are both second line treatments for women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS). Long-term follow-up after electrocautery versus ovulation induction with gonadotrophins has demonstrated at least comparable chances for a first live born child with a reduced need for ovulation induction or assisted reproduction treatment and increased chances for a second live born child. In this study, we report on the long-term economic consequences of both treatment modalities. METHODSBetween February 1998 and October 2001, we performed a multi-centre randomized controlled trial (RCT) comparing a strategy of laparoscopic electrocautery of the ovaries, followed by clomiphene citrate and gonadotrophins when anovulation persisted, and a strategy of ovulation induction with gonadotrophins in women with clomiphene citrate-resistant PCOS. Eight to twelve years after randomization we performed a follow-up study on reproductive outcome in these women and the fertility treatments they had needed including data on direct medical costs of pregnancy and delivery. Clinical data included number of treatment cycles, live births, miscarriages, ectopic pregnancies and multiple pregnancies. We calculated mean costs per woman after randomization until the first live birth. Confidence intervals (CIs) were estimated by bootstrapping. RESULTSWe obtained data for an economic analysis on 159 of the 168 randomized women (95). In total, 71 of 83 women (86) allocated to the electrocautery strategy and 69 of 85 women (81) allocated to the gonadotrophin strategy had at least one live birth. Given the equivalence between the two treatment strategies in terms of a first live birth-the primary outcome measure-our analysis focused on the cost difference between the two strategies within a mean follow-up time of 8-12 years. The mean costs per first live birth after randomization were €11 176 (95 CI: €9689-€12 549) for the electrocautery group and €14 423 (95 CI: €12 239-€16 606) for the recombinant FSH group, resulting in significantly lower costs (P < 0. 05) per first live birth for women allocated to the electrocautery group (mean difference €3247; 95 CI: €650-€5814). CONCLUSIONIn women with clomiphene-resistant PCOS, laparoscopic electrocautery of the ovaries results in significantly lower costs per live birth than ovulation induction with gonadotrophins for an at least equal effectiveness.",
keywords = "cost-effectiveness, electrocautery, gonadotrophins, ovulation induction, polycystic ovary syndrome",
author = "Nahuis, {M. J.} and {Oude Lohuis}, E. and N. Kose and N. Bayram and P. Hompes and Oosterhuis, {G. J E} and Kaaijk, {E. M.} and Cohlen, {B. J.} and Bossuyt, {P. P M} and {Van Der Veen}, F. and Mol, {B. W.} and {Van Wely}, M.",
year = "2012",
month = "1",
day = "1",
doi = "10.1093/humrep/des336",
language = "English",
volume = "27",
pages = "3577--3582",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "12",

}

Nahuis, MJ, Oude Lohuis, E, Kose, N, Bayram, N, Hompes, P, Oosterhuis, GJE, Kaaijk, EM, Cohlen, BJ, Bossuyt, PPM, Van Der Veen, F, Mol, BW & Van Wely, M 2012, 'Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome: An economic evaluation', Human Reproduction, vol. 27, no. 12, pp. 3577-3582. https://doi.org/10.1093/humrep/des336

Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome : An economic evaluation. / Nahuis, M. J.; Oude Lohuis, E.; Kose, N.; Bayram, N.; Hompes, P.; Oosterhuis, G. J E; Kaaijk, E. M.; Cohlen, B. J.; Bossuyt, P. P M; Van Der Veen, F.; Mol, B. W.; Van Wely, M.

In: Human Reproduction, Vol. 27, No. 12, 01.01.2012, p. 3577-3582.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome

T2 - Human Reproduction

AU - Nahuis, M. J.

AU - Oude Lohuis, E.

AU - Kose, N.

AU - Bayram, N.

AU - Hompes, P.

AU - Oosterhuis, G. J E

AU - Kaaijk, E. M.

AU - Cohlen, B. J.

AU - Bossuyt, P. P M

AU - Van Der Veen, F.

AU - Mol, B. W.

AU - Van Wely, M.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - BACKGROUNDLaparoscopic electrocautery of the ovaries and ovulation induction with gonadotrophins are both second line treatments for women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS). Long-term follow-up after electrocautery versus ovulation induction with gonadotrophins has demonstrated at least comparable chances for a first live born child with a reduced need for ovulation induction or assisted reproduction treatment and increased chances for a second live born child. In this study, we report on the long-term economic consequences of both treatment modalities. METHODSBetween February 1998 and October 2001, we performed a multi-centre randomized controlled trial (RCT) comparing a strategy of laparoscopic electrocautery of the ovaries, followed by clomiphene citrate and gonadotrophins when anovulation persisted, and a strategy of ovulation induction with gonadotrophins in women with clomiphene citrate-resistant PCOS. Eight to twelve years after randomization we performed a follow-up study on reproductive outcome in these women and the fertility treatments they had needed including data on direct medical costs of pregnancy and delivery. Clinical data included number of treatment cycles, live births, miscarriages, ectopic pregnancies and multiple pregnancies. We calculated mean costs per woman after randomization until the first live birth. Confidence intervals (CIs) were estimated by bootstrapping. RESULTSWe obtained data for an economic analysis on 159 of the 168 randomized women (95). In total, 71 of 83 women (86) allocated to the electrocautery strategy and 69 of 85 women (81) allocated to the gonadotrophin strategy had at least one live birth. Given the equivalence between the two treatment strategies in terms of a first live birth-the primary outcome measure-our analysis focused on the cost difference between the two strategies within a mean follow-up time of 8-12 years. The mean costs per first live birth after randomization were €11 176 (95 CI: €9689-€12 549) for the electrocautery group and €14 423 (95 CI: €12 239-€16 606) for the recombinant FSH group, resulting in significantly lower costs (P < 0. 05) per first live birth for women allocated to the electrocautery group (mean difference €3247; 95 CI: €650-€5814). CONCLUSIONIn women with clomiphene-resistant PCOS, laparoscopic electrocautery of the ovaries results in significantly lower costs per live birth than ovulation induction with gonadotrophins for an at least equal effectiveness.

AB - BACKGROUNDLaparoscopic electrocautery of the ovaries and ovulation induction with gonadotrophins are both second line treatments for women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS). Long-term follow-up after electrocautery versus ovulation induction with gonadotrophins has demonstrated at least comparable chances for a first live born child with a reduced need for ovulation induction or assisted reproduction treatment and increased chances for a second live born child. In this study, we report on the long-term economic consequences of both treatment modalities. METHODSBetween February 1998 and October 2001, we performed a multi-centre randomized controlled trial (RCT) comparing a strategy of laparoscopic electrocautery of the ovaries, followed by clomiphene citrate and gonadotrophins when anovulation persisted, and a strategy of ovulation induction with gonadotrophins in women with clomiphene citrate-resistant PCOS. Eight to twelve years after randomization we performed a follow-up study on reproductive outcome in these women and the fertility treatments they had needed including data on direct medical costs of pregnancy and delivery. Clinical data included number of treatment cycles, live births, miscarriages, ectopic pregnancies and multiple pregnancies. We calculated mean costs per woman after randomization until the first live birth. Confidence intervals (CIs) were estimated by bootstrapping. RESULTSWe obtained data for an economic analysis on 159 of the 168 randomized women (95). In total, 71 of 83 women (86) allocated to the electrocautery strategy and 69 of 85 women (81) allocated to the gonadotrophin strategy had at least one live birth. Given the equivalence between the two treatment strategies in terms of a first live birth-the primary outcome measure-our analysis focused on the cost difference between the two strategies within a mean follow-up time of 8-12 years. The mean costs per first live birth after randomization were €11 176 (95 CI: €9689-€12 549) for the electrocautery group and €14 423 (95 CI: €12 239-€16 606) for the recombinant FSH group, resulting in significantly lower costs (P < 0. 05) per first live birth for women allocated to the electrocautery group (mean difference €3247; 95 CI: €650-€5814). CONCLUSIONIn women with clomiphene-resistant PCOS, laparoscopic electrocautery of the ovaries results in significantly lower costs per live birth than ovulation induction with gonadotrophins for an at least equal effectiveness.

KW - cost-effectiveness

KW - electrocautery

KW - gonadotrophins

KW - ovulation induction

KW - polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=84870007980&partnerID=8YFLogxK

U2 - 10.1093/humrep/des336

DO - 10.1093/humrep/des336

M3 - Article

VL - 27

SP - 3577

EP - 3582

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 12

ER -